Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years)
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The protocol objective is providing adequate treatment and based on broad consensus in
elderly patients with Acute Lymphoblastic Leukemia (ALL). Apply uniform treatment that
enables a joint analysis of results strong enough to make conclusions on specific subgroups
of patients (genotypic subtypes, particularly LAL Bcr/abl positive, phenotype, or strata of
age or associated diseases). Provide results of a treatment to consider standard against
which to compare the results of phase II trials of experimental drugs that undoubtedly will
be activated in the coming years